These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2458582)
21. Lysosomal localization of secretory prostatic acid phosphatase in human hyperplastic prostate epithelium. Zondervan PE; van der Kwast TH; de Jong A; Visser WJ; de Bruijn WC Urol Res; 1986; 14(6):331-5. PubMed ID: 2433829 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemistry of acid phosphatase in the human prostate: normal and pathologic. Cytochemistry and biochemistry of acid phosphatases II. Aumüller G; Pohl C; van Etten RL; Seitz J Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 35(3):249-62. PubMed ID: 6169193 [TBL] [Abstract][Full Text] [Related]
23. Isozymes of acid phosphatase in normal and cancerous human prostatic tissue. Foti AG; Herschman H; Cooper JF Cancer Res; 1977 Nov; 37(11):4120-4. PubMed ID: 908045 [TBL] [Abstract][Full Text] [Related]
24. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709 [TBL] [Abstract][Full Text] [Related]
25. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552 [TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy. Mahan DE; Bruce AW; Manley PN; Franchi L J Urol; 1980 Oct; 124(4):488-91. PubMed ID: 6158585 [TBL] [Abstract][Full Text] [Related]
29. Immunofluorescent localization of an androgen-dependent isoenzyme of prostatic acid phosphatase in rat ventral prostate. Terracio L; Rule A; Salvato J; Douglas WH Anat Rec; 1985 Oct; 213(2):131-9. PubMed ID: 3907418 [TBL] [Abstract][Full Text] [Related]
30. Elevation of serum prostatic acid phosphatase levels after prostatic massage. Wadström J; Huber P; Rutishauser G Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846 [TBL] [Abstract][Full Text] [Related]
31. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]. Mathieu MC; Caillaud JM Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371 [TBL] [Abstract][Full Text] [Related]
32. Localization of type IV collagen in the basement membranes of human prostate and lymph nodes by immunoperoxidase and immunoalkaline phosphatase. Sinha AA; Gleason DF; DeLeon OF; Wilson MJ; Limas C; Reddy PK; Furcht LT Prostate; 1991; 18(2):93-104. PubMed ID: 1706514 [TBL] [Abstract][Full Text] [Related]
33. Biochemical and electrophoretic properties of acid phosphatase isozymes and their distribution in cell functions from neoplastic prostatic tissues. Fischer DR; Gevers W Urol Int; 1980; 35(3):216-25. PubMed ID: 6155728 [TBL] [Abstract][Full Text] [Related]
34. Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade. Zhou R; Hammond EH; Sause WT; Rubin P; Emami B; Pilepich MV; Asbell SD; Parker DL Mod Pathol; 1994 May; 7(4):440-8. PubMed ID: 7520585 [TBL] [Abstract][Full Text] [Related]
35. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160 [TBL] [Abstract][Full Text] [Related]
36. Enzyme activity and distribution in the hyperplastic and cancerous human prostate. Müntzing J; Nilsson T Scand J Urol Nephrol; 1972; 6(2):107-11. PubMed ID: 4114364 [No Abstract] [Full Text] [Related]
37. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System. Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985 [TBL] [Abstract][Full Text] [Related]
38. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium. Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845 [TBL] [Abstract][Full Text] [Related]
39. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies. Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771 [TBL] [Abstract][Full Text] [Related]
40. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]